Maynard Um
-
-
-
-
-
-
-
Syndax Pharmaceuticals (SNDX) Reiterated at Buy by Stifel
-
-
-
-
-
-
-
Syndax Pharmaceuticals (SNDX) PT Raised to $29 at BofA Securities
-
-
-
-
-
-
-
Syndax Pharmaceuticals (SNDX) Misses Q4 EPS by 19c
-
-
-
-
-
-
-
Syndax Pharmaceuticals (SNDX) PT Raised to $27 at Goldman Sachs
-
-
-
-
-
-
-
BofA Shuffles Endeavor List Names
-
-
-
-
-
-
-
Syndax Pharmaceuticals (SNDX) PT Raised to $20 at Goldman Sachs
-
-
-
-
-
-
-
Syndax Pharmaceuticals (SNDX) announces data from BEAT AML trial evaluating revumenib
-
422,863 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

